Doxazosin Mesylate

Generic name

Doxazosin Mesylate

Covered by Medicare

Yes

Get a Medicare Quote

Average Annual Cost per Beneficiary

$100.70

Average cost per year*

Average Annual Cost per Dose

$0.31

-22.16%

Average cost per beneficiary*

Manufacturer(s)

  • Zydus Pharmaceu
  • Upsher-Smith La
  • Teva USA
  • Qualitest/Par P
  • Mylan Instituti
  • Mylan
  • Major Pharmaceu
  • Greenstone LLC.
  • Avkare
  • Avet Pharmaceut
  • Apotex Corp
  • Accord Healthca

What is Doxazosin Mesylate

Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication works by relaxing blood vessels so blood can flow more easily. Doxazosin is also used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and part of the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). Doxazosin belongs to a class of drugs known as alpha blockers. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Drug Trends

*Origin of the terms and chart data used within this page: https://data.cms.gov/

Common Questions About Doxazosin Mesylate

Yes, Doxazosin Mesylate is covered by Medicare.

In 2021, the average cost per dose of Doxazosin Mesylate was $0.31.

The average dose of Doxazosin Mesylate received per year is 168,379,014 units

544,995 Medicare beneficiaries received Doxazosin Mesylate in 2021, which was a 0% from 2020

There were 2,289,565 claims made by Medicare beneficiaries, which is a -0.04% from 2020

The average spending amount per claim in 2021 was $23.97

The average Medicare spending per beneficiary amount for Doxazosin Mesylate was $100.70

The most expensive manufacturer of Doxazosin Mesylate is Mylan Instituti

Avet Pharmaceut is the least expensive manufacturer with an Average Spending Per Dosage Unit of $0.20

Accord Healthca received $22,977,909.36

The total amount spent on Doxazosin Mesylate by Medicare is $54,881,306.98

© 2021-2024 HealthInsurance.com, LLC

Privacy Policy  |  Terms and Conditions

GENERAL DISCLAIMERS

Healthinsurance.com is a commercial site designed for the solicitation of insurance from selected health insurance carriers and HealthInsurance.com, LLC is a licensed insurance agency. It is not a government agency. It is also not an insurer, or a medical provider. HealthInsurance.com, LLC is a licensed representative of Medicare Advantage (HMO, PPO, PFFS, and PDP) organizations that have a Medicare contract. Enrollment depends on the plan’s contract renewal.
We do not offer every plan available in your area. Currently we represent nine carrier plan organizations nationally. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.
Alternatively, you may be referred, via a link, to a selected partner website, which is independently owned and operated and may have different privacy and terms of use policies from us.
If you provide your contact information to us, an insurance agent/producer or insurance company may contact you. If you do not speak English, language assistance service, free of charge, is available to you; contact the toll-free number listed above. This site is not maintained by or affiliated with the federal government's Health Insurance Marketplace website or any state government health insurance marketplace.
The plans we represent do not discriminate on the basis of race, color, national origin, age, disability, or sex. To learn more about a plan's nondiscrimination policy, please click here.
Not all plans offer all of these benefits. Benefits may vary by carrier and location. Limitations and exclusions may apply.
Multi-Plan_HIC_Web_M